OpenLegislation

Commission Regulation (EU) No 544/2011 of 10 June 2011 implementing Regulation (EC) No 1107/2009 of the European Parliament and of the Council as regards the data requirements for active substances (Text with EEA relevance) (repealed)

EU Regulation No 544/2011 · Adopted 10 June 2011 · Extends to United Kingdom

Original text. legislation.gov.uk does not revise this item, so later amendments are not shown here. Changes made to it are listed under each provision when known.

F1Commission Regulation (EU) No 544/2011

of 10 June 2011

implementing Regulation (EC) No 1107/2009 of the European Parliament and of the Council as regards the data requirements for active substances

(Text with EEA relevance) (repealed)

THE EUROPEAN COMMISSION,

Having regard to the Treaty on the Functioning of the European Union,

Having regard to Regulation (EC) No 1107/2009 of the European Parliament and of the Council of 21 October 2009 concerning the placing of plant protection products on the market and repealing Council Directives 79/117/EEC and 91/414/EEC, and in particular the first sentence of Article 8(4) thereof,

After consulting the Standing Committee on the Food Chain and Animal Health,

Whereas:

(1)

In accordance with Regulation (EC) No 1107/2009, the dossier to be submitted for the approval of an active substance or for the authorisation of a plant protection product is to fulfil the same requirements in respect of the data requirements for the plant protection product as under the previously applicable rules which are set out in Annexes II and III to Council Directive 91/414/EEC of 15 July 1991 concerning the placing of plant protection products on the market.

(2)

It is therefore necessary for the implementation of Regulation (EC) No 1107/2009 to adopt a regulation containing those data requirements for active substances. Such a regulation is not to include any substantial modification,

HAS ADOPTED THIS REGULATION:

Annotations to the whole text

Textual amendments

F1

Repealed (subject to transitional measures in Arts. 3, 4) by Commission Regulation (EU) No 283/2013 of 1 March 2013 setting out the data requirements for active substances, in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market Text with EEA relevance.

Contents

  1. A1Scope and interpretation
  2. 1Article 1
  3. 2Article 2 Repealed
  4. Signature
  5. Annex: DATA REQUIREMENTS FOR ACTIVE SUBSTANCES, AS PROVIDED FOR IN ARTICLE 8(1)(b) OF REGULATION (EC) No 1107/2009
  6. INTRODUCTION
  7. 1Division 1
  8. Test and analyses
  9. 2.1Division 2.1
  10. 2.2By way of derogation from point 2.1, the competent authority may provide that tests and analyses, performed on their constituent territory in order to obtain data on the properties and/or safety of the active substances with respect to honey-bees and beneficial arthropods other than bees shall be conducted by official or officially-recognised testing facilities or organisations which satisfy at least the requirements as set out under points 2.2 and 2.3 of the introduction to the Annex to Commission Regulation (EU) No 545/2011.
  11. 2.3By way of derogation from point 2.1, the competent authority may provide that supervised residue trials performed on their constituent territory in accordance with Section 6 ‘Residues in or on treated products, food and feed’ on plant protection products containing active substances already on the market on or before 25th July 1993 shall be conducted by official or officially-recognised testing facilities or organisations which satisfy at least the requirements under points 2.2 and 2.3 of the introduction to the Annex to Regulation (EU) No 545/2011.
  12. 2.4Division 2.4
  13. Part A: CHEMICAL SUBSTANCES
  14. 1Identity of the active substance
  15. 1.1Applicant (name, address, etc.)
  16. 1.2Manufacturer (name, address, including location of plant)
  17. 1.3Common name proposed or ISO-accepted, and synonyms
  18. 1.4Chemical name (IUPAC and CA nomenclature)
  19. 1.4.1Division 1.4.1
  20. 1.5Manufacturer’s development code number(s)
  21. 1.6CAS, EC and CIPAC numbers (if available)
  22. 1.7Molecular and structural formula, molecular mass
  23. 1.8Method of manufacture (synthesis pathway) of the active substance
  24. 1.9Specification of purity of the active substance in g/kg
  25. 1.10Identity of isomers, impurities and additives (e.g. stabilisers), together with the structural formula and the content expressed as g/kg
  26. 1.11Analytical profile of batches
  27. Physical and chemical properties of the active substance
  28. (i)The information provided, must describe the physical and chemical properties of active substances and together with relevant information, must serve to characterise them. In particular, the information provided must permit:
  29. (ii)Division (ii)
  30. (iii)Division (iii)
  31. (iv)In certain specified instances, tests must be conducted using purified active substance of stated specification. In such cases the principles of the method(s) of purification must be reported. The purity of such test material, which must be as high as can be achieved using the best available technology, must be reported. A reasoned justification must be provided in cases where the degree of purity achieved is less than 980 g/kg.
  32. Melting point and boiling point
  33. 2.1.1Division 2.1.1
  34. 2.1.2Division 2.1.2
  35. 2.1.3Division 2.1.3
  36. 2.2Relative density
  37. Vapour pressure (in Pa), volatility (e.g. Henry’s law constant)
  38. 2.3.1Division 2.3.1
  39. 2.3.2Division 2.3.2
  40. Appearance (physical state, colour and odour; if known)
  41. 2.4.1Division 2.4.1
  42. 2.4.2Division 2.4.2
  43. Spectra (UV/VIS, IR, NMR, MS), molecular extinction at relevant wavelengths
  44. 2.5.1Division 2.5.1
  45. 2.5.2Division 2.5.2
  46. 2.6Solubility in water including effect of pH (4 to 10) on solubility
  47. 2.7Solubility in organic solvents
  48. 2.8Partition coefficient n-octanol/water including effect of pH (4 to 10)
  49. Stability in water, hydrolysis rate, photochemical degradation, quantum yield and identity of breakdown product(s), dissociation constant including effect of pH (4 to 9)
  50. 2.9.1Division 2.9.1
  51. 2.9.2Division 2.9.2
  52. 2.9.3Division 2.9.3
  53. 2.9.4Division 2.9.4
  54. 2.10Stability in air, photochemical degradation, identity of breakdown product(s)
  55. Flammability including auto-flammability
  56. 2.11.1Division 2.11.1
  57. 2.11.2Division 2.11.2
  58. 2.12Flash point
  59. 2.13Explosive properties
  60. 2.14Surface tension
  61. 2.15Oxidising properties
  62. Further information on the active substance
  63. (i)Division (i)
  64. (ii)Division (ii)
  65. (iii)Division (iii)
  66. (iv)Division (iv)
  67. (v)Division (v)
  68. 3.1Function, e.g. fungicide, herbicide, insecticide, repellent, growth regulator
  69. Effects on harmful organisms, e.g. contact poison, inhalation poison, stomach poison, fungitoxic, etc. systematic or not in plants
  70. 3.2.1Division 3.2.1
  71. 3.2.2Division 3.2.2
  72. 3.3Field of use envisaged, e.g. field, protected crops, storage of plant products, home gardening
  73. Harmful organisms controlled and crops or products protected or treated
  74. 3.4.1Division 3.4.1
  75. 3.4.2Division 3.4.2
  76. 3.4.3Division 3.4.3
  77. Mode of action
  78. 3.5.1Division 3.5.1
  79. 3.5.2Division 3.5.2
  80. 3.5.3Division 3.5.3
  81. 3.6Information on the occurrence or possible occurrence of the development of resistance and appropriate management strategies
  82. 3.7Recommended methods and precautions concerning handling, storage, transport or fire
  83. Procedures for destruction or decontamination
  84. 3.8.1Controlled incineration
  85. 3.8.2Others
  86. 3.9Emergency measures in case of an accident
  87. Analytical methods
  88. Introduction
  89. 4.1Methods for the analysis of the active substance as manufactured
  90. (i)Specificity
  91. (ii)Linearity
  92. (iii)Accuracy
  93. (iv)Precision
  94. 4.1.1Division 4.1.1
  95. 4.1.2Division 4.1.2
  96. Specificity, linearity, accuracy and repeatability
  97. 4.1.3.1Division 4.1.3.1
  98. 4.1.3.2Division 4.1.3.2
  99. 4.1.3.3Division 4.1.3.3
  100. 4.1.3.4Division 4.1.3.4
  101. 4.2Methods for the determination of residues
  102. (i)Specificity
  103. (ii)Precision
  104. (iii)Recovery
  105. (iv)Limit of determination
  106. 4.2.1Residues in and/or on plants, plant products, foodstuffs (of plant and animal origin), feedingstuffs
  107. 4.2.2Residues in soil
  108. 4.2.3Residues in water (including drinking water, ground water and surface water)
  109. 4.2.4Residues in air
  110. 4.2.5Residues in body fluids and tissues
  111. Toxicological and metabolism studies
  112. Introduction
  113. (i)The information provided, taken together with that provided for one or more preparations containing the active substance, must be sufficient to permit an evaluation to be made as to the risks for man, associated with the handling and use of plant protection products containing the active substance, and the risk for man arising from residual traces remaining in food and water. In addition, the information provided must be sufficient to:
  114. (ii)Division (ii)
  115. (iii)Division (iii)
  116. (iv)Division (iv)
  117. (v)Division (v)
  118. (vi)Division (vi)
  119. (vii)Division (vii)
  120. (viii)Division (viii)
  121. 5.1Studies on absorption, distribution, excretion and metabolism in mammals
  122. Circumstances in which required
  123. Test guideline
  124. 5.2Acute toxicity
  125. Oral
  126. Circumstances in which required
  127. Test guideline
  128. Percutaneous
  129. Circumstances in which required
  130. Test guideline
  131. Inhalation
  132. Circumstances in which required
  133. Test guideline
  134. Skin irritation
  135. Aim of the test
  136. Circumstances in which required
  137. Test guideline
  138. Eye irritation
  139. Aim of test
  140. Circumstances in which required
  141. Test guidelines
  142. Skin sensitisation
  143. Aim of test
  144. Circumstances in which required
  145. Test guideline
  146. 5.3Short-term toxicity
  147. Oral 28-day study
  148. Circumstances in which required
  149. Test guideline
  150. Oral 90-day study
  151. Circumstances in which required
  152. Test guidelines
  153. Other routes
  154. Circumstances in which required
  155. Test guidelines
  156. Genotoxicity testing
  157. Aim of the test
  158. In vitro studies
  159. Circumstances in which required
  160. Test guidelines
  161. In vivo studies in somatic cells
  162. Circumstances in which required
  163. Test guidelines
  164. In vivo studies in germ cells
  165. Circumstances in which required
  166. Long-term toxicity and carcinogenicity
  167. Aim of the test
  168. Circumstances in which required
  169. Test conditions
  170. Test guideline
  171. 5.6Reproductive toxicity
  172. Multi-generation studies
  173. Aim of the test
  174. Circumstances in which required
  175. Test guideline
  176. Supplementary studies
  177. Developmental toxicity studies
  178. Aim of the test
  179. Circumstances in which required
  180. Test conditions
  181. Test guideline
  182. Delayed neurotoxicity studies
  183. Aim of the test
  184. Circumstances in which required
  185. Test guidelines
  186. Other toxicological studies
  187. 5.8.1Toxicity studies of metabolites as referred to in the introduction, point (vii)
  188. 5.8.2Supplementary studies on the active substance
  189. 5.9Medical data
  190. 5.9.1Medicinal surveillance on manufacturing plant personnel
  191. 5.9.2Direct observation, e.g. clinical cases and poisoning incidents
  192. 5.9.3Observations on exposure of the general population and epidemiological studies if appropriate
  193. 5.9.4Diagnosis of poisoning (determination of active substance, metabolites), specific signs of poisoning, clinical tests
  194. 5.9.5Proposed treatment: first aid measures, antidotes, medical treatment
  195. 5.9.6Expected effects of poisoning
  196. 5.10Summary of mammalian toxicity and overall evaluation
  197. Residues in or on treated products, food and feed
  198. Introduction
  199. (i)The information provided, taken together with that provided for one or more preparations containing the active substance, must be sufficient to permit an evaluation to be made as to the risks for man, arising from residues of the active substance and relevant metabolites, degradation and reaction products remaining in food. In addition, the information provided must be sufficient to:
  200. (ii)Division (ii)
  201. (iii)Division (iii)
  202. (iv)Division (iv)
  203. (v)Stability of residues during storage.
  204. Metabolism, distribution and expression of residue in plants
  205. Aim of the tests
  206. Circumstances in which required
  207. Test conditions
  208. Metabolism, distribution and expression of residue in livestock
  209. Aim of tests
  210. Circumstances in which required
  211. Residue trials
  212. Aim of the tests
  213. Circumstances in which required
  214. Test conditions
  215. Livestock feeding studies
  216. Aim of the tests
  217. Circumstances in which required
  218. Test conditions
  219. Effects of industrial processing and/or household preparations
  220. Circumstances in which required
  221. Effects on the nature of the residue
  222. Aim of the tests
  223. Test conditions
  224. Effects on the residue levels
  225. Aim of the tests
  226. Test conditions
  227. Residues in succeeding crops
  228. Aim of the test
  229. Circumstances in which required
  230. Test conditions
  231. 6.7Proposed maximum residue levels (MRLs) and residue definition
  232. 6.8Proposed pre-harvest intervals for envisaged uses, or withholding periods or storage periods, in the case of post-harvest uses
  233. 6.9Estimation of the potential and actual exposure through diet and other means
  234. 6.10Summary and evaluation of residue behaviour
  235. Fate and behaviour in the environment
  236. Introduction
  237. (i)Division (i)
  238. (ii)In particular, the information provided for the active substance, together with other relevant information, and that provided for one or more preparations containing it shall be sufficient to:
  239. (iii)A detailed description (specification) of the material used, as provided for under point 1.11 must be provided. Where testing is done using active substance the material used shall be of that specification that will be used in the manufacture of preparations to be authorised except where radio-labelled material is used.
  240. (iv)Division (iv)
  241. (v)Division (v)
  242. (vi)Where relevant, tests shall be designed and data analysed using appropriate statistical methods.
  243. 7.1Fate and behaviour in soil
  244. Route and rate of degradation
  245. Route of degradation
  246. Aim of the tests
  247. Aerobic degradation
  248. Circumstances in which required
  249. Test conditions
  250. Test guideline
  251. Supplementary studies
  252. Anaerobic degradation
  253. Circumstances in which required
  254. Test conditions and test guideline
  255. Soil photolysis
  256. Circumstances in which required
  257. Test guideline
  258. Rate of degradation
  259. Laboratory studies
  260. Aim of the tests
  261. Aerobic degradation
  262. Circumstances in which required
  263. Test conditions
  264. Test guideline
  265. Anaerobic degradation
  266. Circumstances in which required
  267. Test conditions
  268. Test guideline
  269. Field studies
  270. Soil dissipation studies
  271. Aim of the test
  272. Circumstances in which required
  273. Test conditions
  274. Test guideline
  275. Soil residue studies
  276. Aim of the test
  277. Circumstances in which required
  278. Test conditions
  279. Test guideline
  280. Soil accumulation studies
  281. Aim of the tests
  282. Circumstances in which required
  283. Test conditions
  284. Adsorption and desorption
  285. Aim of the test
  286. Circumstances in which required
  287. Test conditions
  288. Test guideline
  289. Mobility in the soil
  290. Column leaching studies
  291. Aim of the test
  292. Circumstances in which required
  293. Test guideline
  294. Aged residue column leaching
  295. Aim of the test
  296. Circumstances in which required
  297. Test conditions
  298. Test guideline
  299. Lysimeter studies or field leaching studies
  300. Aim of the tests
  301. Circumstances in which required
  302. Test conditions
  303. Lysimeter studies
  304. Test conditions
  305. Field leaching studies
  306. Test conditions
  307. Test guideline
  308. Fate and behaviour in water and air
  309. Aim of the tests
  310. Route and rate of degradation in aquatic systems (as far as not covered by point 2.9)
  311. Aim of the tests
  312. Hydrolytic degradation
  313. Circumstances in which required
  314. Test conditions and test guideline
  315. Photochemical degradation
  316. Circumstances in which required
  317. Test conditions and test guideline
  318. Biological degradation
  319. ‘Ready biodegradability’
  320. Circumstances in which required
  321. Test guideline
  322. Water/sediment study
  323. Circumstances in which required
  324. Test guideline
  325. Degradation in the saturated zone
  326. Circumstances in which required
  327. Test conditions
  328. 7.2.2Route and rate of degradation in air (as far as not covered by point 2.10)
  329. 7.3Definition of the residue
  330. 7.4Monitoring data
  331. Ecotoxicological studies
  332. Introduction
  333. (i)Division (i)
  334. (ii)In particular, the information provided for the active substance, together with other relevant information, and that provided for one or more preparations containing it, shall be sufficient to:
  335. (iii)Division (iii)
  336. (iv)Division (iv)
  337. (v)Division (v)
  338. Test substance
  339. (vi)Division (vi)
  340. (vii)Division (vii)
  341. (viii)In the case of studies in which dosing extends over a period, dosing shall preferably be done using a single batch of active substance if stability permits.
  342. (ix)Division (ix)
  343. (x)Division (x)
  344. Test organisms
  345. (xi)Division (xi)
  346. Effects on birds
  347. Acute oral toxicity
  348. Aim of the test
  349. Circumstances in which required
  350. Test conditions
  351. Test guideline
  352. Short-term dietary toxicity
  353. Aim of the test
  354. Circumstances in which required
  355. Test conditions
  356. Test guideline
  357. Subchronic toxicity and reproduction
  358. Aim of the test
  359. Circumstances in which required
  360. Test guideline
  361. 8.2Effects on aquatic organisms
  362. Acute toxicity to fish
  363. Aim of the test
  364. Circumstances in which required
  365. Test conditions
  366. Test guideline
  367. Chronic toxicity to fish
  368. Circumstances in which required
  369. Chronic toxicity test on juvenile fish
  370. Aim of the test
  371. Test conditions
  372. Fish early life stage toxicity test
  373. Aim of the test
  374. Test guideline
  375. Fish life cycle test
  376. Aim of the test
  377. Test conditions
  378. Bioconcentration in fish
  379. Aim of the test
  380. Circumstances in which required
  381. Test guideline
  382. Acute toxicity to aquatic invertebrates
  383. Aim of the test
  384. Circumstances in which required
  385. Test guideline
  386. Chronic toxicity to aquatic invertebrates
  387. Aim of the test
  388. Circumstances in which required
  389. Test conditions
  390. Test guideline
  391. Effects on algal growth
  392. Aim of the test
  393. Circumstances in which required
  394. Test guideline
  395. Effects on sediment dwelling organisms
  396. Aim of test
  397. Circumstances in which required
  398. Test conditions
  399. 8.2.8Aquatic plants
  400. Effect on arthropods
  401. Bees
  402. Acute toxicity
  403. Aim of the test
  404. Circumstances in which required
  405. Test guideline
  406. Bee brood feeding test
  407. Aim of the test
  408. Circumstances in which required
  409. Test guideline
  410. Other arthropods
  411. Aim of the test
  412. Circumstances in which required
  413. Test conditions
  414. Test guideline
  415. Effects on earthworms
  416. Acute toxicity
  417. Aim of the test
  418. Circumstances in which required
  419. Test guideline
  420. Sublethal effects
  421. Aim of the test
  422. Circumstances in which required
  423. Test conditions
  424. Effects on soil non-target micro-organisms
  425. Aim of the test
  426. Circumstances in which required
  427. Test conditions
  428. Test guideline
  429. 8.6Effects on other non-target organisms (flora and fauna) believed to be at risk
  430. 8.7Effects on biological methods for sewage treatment
  431. Summary and evaluation of Sections 7 and 8
  432. 10Proposals including justification for the proposals for the classification and labelling of the active substance in accordance with Regulation (EC) No 1272/2008
  433. A dossier as referred to in Part A of the Annex to Regulation (EU) No 545/2011, for a representative plant protection product
  434. Part B: MICRO-ORGANISMS INCLUDING VIRUSES
  435. Introduction
  436. (i)Active substances are defined in Article 2(2) of Regulation (EC) No 1107/2009 and include chemical substances and micro-organisms including viruses.
  437. (ii)For all micro-organisms that are subject to application all available relevant knowledge and information in literature should be provided.
  438. (iii)Division (iii)
  439. (iv)Where testing is done, a detailed description (specification) of the material used and its impurities, in accordance with point 1.4, must be provided. The material used shall be of that specification that will be used in the manufacture of preparations to be authorised.
  440. (v)Division (v)
  441. (vi)Division (vi)
  442. (vii)In the case of studies in which dosing extends over a period, dosing shall preferably be done using a single batch of the micro-organism, if stability permits.
  443. (viii)Division (viii)
  444. 1Identity of the micro-organism
  445. 1.1Applicant
  446. 1.2Producer
  447. Name and species description, strain characterisation
  448. (i)Division (i)
  449. (ii)Each micro-organism that is subject to the application shall be identified and named at the species level. The scientific name and taxonomic grouping, i.e. family, genus, species, strain, serotype, pathovar or any other denomination relevant to the micro-organism, must be stated.
  450. (iii)Division (iii)
  451. (iv)Division (iv)
  452. (v)Division (v)
  453. Specification of the material used for manufacturing of formulated products
  454. 1.4.1Content of the micro-organism
  455. 1.4.2Identity and content of impurities, additives, contaminating micro-organisms
  456. 1.4.3Analytical profile of batches
  457. Biological properties of the micro-organism
  458. 2.1History of the micro-organism and its uses. Natural occurrence and geographical distribution
  459. 2.1.1Historical background
  460. 2.1.2Origin and natural occurrence
  461. Information on target organism(s)
  462. 2.2.1Description of the target organism(s)
  463. 2.2.2Mode of action
  464. 2.3Host specificity range and effects on species other than the target harmful organism
  465. 2.4Development stages/life cycle of the micro-organism
  466. 2.5Infectiveness, dispersal and colonisation ability
  467. 2.6Relationships to known plant or animal or human pathogens
  468. 2.7Genetic stability and factors affecting it
  469. 2.8Information on the production of metabolites (especially toxins)
  470. 2.9Antibiotics and other anti-microbial agents
  471. Further information on the micro-organism
  472. Introduction
  473. (i)Division (i)
  474. (ii)Division (ii)
  475. (iii)Division (iii)
  476. (iv)Division (iv)
  477. 3.1Function
  478. 3.2Field of use envisaged
  479. 3.3Crops or products protected or treated
  480. 3.4Method of production and quality control
  481. 3.5Information on the occurrence or possible occurrence of the development of resistance of the target organism(s)
  482. 3.6Methods to prevent loss of virulence of seed stock of the micro-organism
  483. 3.7Recommended methods and precautions concerning handling, storage, transport or fire
  484. 3.8Procedures for destruction or decontamination
  485. 3.9Measures in case of an accident
  486. Analytical methods
  487. Introduction
  488. 4.1Methods for the analysis of the micro-organism as manufactured
  489. 4.2Methods to determine and quantify residues (viable or non-viable)
  490. Effects on human health
  491. Introduction
  492. (i)Division (i)
  493. (ii)The information provided, taken together with that provided for one or more preparations containing the micro-organism, must be sufficient to permit an evaluation to be made as to the risks for man, directly and/or indirectly associated with the handling and use of plant protection products containing the micro-organism, and the risk for man handling treated products, and the risk for man arising from residual traces or contaminants remaining in food and water. In addition, the information provided must be sufficient to:
  494. (iii)Division (iii)
  495. (iv)Division (iv)
  496. (v)Evaluation of the micro-organism shall be carried out in a tier-wise manner.
  497. TIER I
  498. 5.1Basic information
  499. 5.1.1Medical data
  500. 5.1.2Medical surveillance on manufacturing plant personnel
  501. 5.1.3Sensitisation/allergenicity observations, if appropriate
  502. 5.1.4Direct observation, e.g. clinical cases
  503. 5.2Basic studies
  504. Sensitisation
  505. Aim of the test
  506. Circumstances in which required
  507. 5.2.2Acute toxicity, pathogenicity and infectiveness
  508. Acute oral toxicity, pathogenicity and infectiveness
  509. Circumstances in which required
  510. Acute inhalation toxicity, pathogenicity and infectiveness
  511. Circumstances in which required
  512. 5.2.2.3Intraperitoneal/subcutaneous single dose
  513. Circumstances in which required
  514. Genotoxicity testing
  515. Circumstances in which required
  516. Aim of the test
  517. Test conditions
  518. In vitro studies
  519. Circumstances in which required
  520. 5.2.4Cell culture study
  521. Information on short-term toxicity and pathogenicity
  522. Aim of the test
  523. Circumstances in which required
  524. 5.2.5.1Health effects after repeated inhalatory exposure
  525. Circumstances in which required
  526. 5.2.6Proposed treatment: first aid measures, medical treatment
  527. TIER II
  528. 5.3Specific toxicity, pathogenicity and infectiveness studies
  529. In vivo studies in somatic cells
  530. Circumstances in which required
  531. Genotoxicity — In vivo studies in germ cells
  532. Aim of the test and test conditions
  533. Circumstances in which required
  534. 5.6Summary of mammalian toxicity, pathogenicity and infectiveness and overall evaluation
  535. Residues in or on treated products, food and feed
  536. Introduction
  537. (i)Division (i)
  538. (ii)In addition, the information provided must be sufficient to:
  539. (iii)Division (iii)
  540. 6.1Persistence and likelihood of multiplication in or on crops, feedingstuffs or foodstuffs
  541. 6.2Further information required
  542. 6.2.1Non-viable residues
  543. 6.2.2Viable residues
  544. Summary and evaluation of residue behaviour resulting from data submitted under points 6.1 and 6.2
  545. Fate and behaviour in the environment
  546. Introduction
  547. (i)Information on the origin, the properties, and the survival of the micro-organism and its residual metabolites as well as its intended use form the basis for an assessment of environmental fate and behaviour.
  548. (ii)Division (ii)
  549. (iii)In particular, the information provided shall be sufficient to:
  550. (iv)Any relevant metabolites (i.e. of concern for human health and/or the environment) formed by the test organism under any relevant environmental conditions shall be characterised. If relevant metabolites are present in or produced by the micro-organism, data as outlined under Section 7 of Part A of this Annex may be required, if all of the following conditions are met:
  551. (v)Division (v)
  552. (vi)Division (vi)
  553. 7.1Persistence and multiplication
  554. 7.1.1Soil
  555. 7.1.2Water
  556. 7.1.3Air
  557. 7.2Mobility
  558. Effects on non-target organisms
  559. Introduction
  560. (i)The information on identity, biological properties and further information in Sections 1, 2, 3 and 7 is central to the assessment of impact on non-target species. Additional useful information may be found on fate and behaviour in the environment in Section 7 and on residue levels in plants in Section 6 which, together with information on the nature of the preparation and its manner of use, defines the nature and extent of potential exposure. The information submitted in accordance with Section 5 will provide essential information as to effects to mammals and the mechanisms involved.
  561. (ii)Division (ii)
  562. (iii)Division (iii)
  563. (iv)In particular, the information provided for the micro-organism, together with other relevant information, and that provided for one or more preparations containing it, shall be sufficient to:
  564. (v)Division (v)
  565. (vi)Division (vi)
  566. (vii)Division (vii)
  567. (viii)Division (viii)
  568. (ix)Division (ix)
  569. Effects on birds
  570. Aim of the test
  571. Effects on aquatic organisms
  572. Aim of the test
  573. Effects on fish
  574. Aim of the test
  575. Effects on freshwater invertebrates
  576. Aim of the test
  577. Effects on algae growth
  578. Aim of the test
  579. Effects on plants other than algae
  580. Aim of the test
  581. Effects on bees
  582. Aim of the test
  583. Effects on arthropods other than bees
  584. Aim of the test
  585. Effects on earthworms
  586. Aim of the test
  587. 8.6Effects on non-target soil micro-organisms
  588. 8.7Additional studies
  589. 9Summary and evaluation of environmental impact